In 2020, Maharjan et al., using bioinformatics analysis, identified 16 biomarkers for lung cancer including Cyclin-B2 (CCNB2), Cell Division Cycle 20 (CDC20), F-Box And Leucine Rich Repeat Protein 3 (FBXL3), and Forkhead Box A2 (FOXA2) [20]. This evidence concerns the gene FBXL3 and lung cancer.